Evogene Ltd. files 20-F

Evogene Ltd. reported a net loss of $7.8 million for the year ended December 31, 2025, a decrease from the $18.1 million loss in 2024, primarily due to a gain on the sale of Lavie Bio's activities and the MicroBoost AI for Ag platform. The company's management has identified conditions that raise substantial doubt about its ability to continue as a going concern, but has prepared a plan to improve liquidity through cost preservation and potential collaborations.